Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,265,100 | -5,086,200 | -4,118,900 | 14,979,500 | 3,919,400 |
| Depreciation Amortization | 6,209,500 | 6,771,200 | 7,528,100 | 6,724,400 | 7,486,500 |
| Income taxes - deferred | -660,900 | -1,255,700 | -7,783,100 | -1,443,900 | -7,380,100 |
| Accounts receivable | -358,800 | -37,000 | -188,300 | -191,000 | -1,034,300 |
| Other Working Capital | 2,102,900 | -1,292,100 | 933,900 | -726,500 | -1,272,200 |
| Other Operating Activity | 5,211,100 | 6,539,900 | 9,707,300 | -17,896,800 | 2,886,800 |
| Operating Cash Flow | $7,238,700 | $5,640,100 | $6,079,000 | $1,445,700 | $4,606,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,569,600 | 6,259,300 | 15,153,300 | N/A | N/A |
| PPE Investments | -351,500 | -223,100 | -342,800 | -298,100 | -314,800 |
| Net Acquisitions | -80,600 | N/A | -5,290,400 | 32,605,300 | -37,510,100 |
| Purchase Of Investment | -3,938,000 | -2,471,700 | -9,783,800 | -15,743,500 | -24,300 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 883,000 |
| Purchase Sale Intangibles | -58,300 | 0 | -614,300 | -2,000 | -154,700 |
| Other Investing Activity | -58,300 | -466,000 | -614,300 | 7,769,600 | -154,700 |
| Investing Cash Flow | $-2,858,800 | $3,098,500 | $-878,000 | $24,333,300 | $-37,120,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,900 | 2,657,000 | 3,550,000 | 1,050,000 | 30,137,700 |
| Debt Repayment | -1,044,900 | -8,804,500 | -6,413,600 | -10,848,700 | -5,134,200 |
| Common Stock Issued | 91,200 | 102,400 | 183,400 | 172,100 | 4,301,100 |
| Common Stock Repurchased | -840,600 | -2,775,400 | -493,000 | -15,076,400 | -118,000 |
| Dividend Paid | -974,400 | -1,049,800 | -1,218,200 | -278,400 | -208,100 |
| Other Financing Activity | -9,300 | 190,200 | -737,800 | -161,100 | 4,388,800 |
| Financing Cash Flow | $-2,766,100 | $-9,680,100 | $-5,129,200 | $-25,142,500 | $33,367,300 |
| Exchange Rate Effect | 9,100 | 4,700 | 21,400 | -8,500 | -6,500 |
| Beginning Cash Position | 880,400 | 1,817,200 | 1,724,000 | 1,096,000 | 250,000 |
| End Cash Position | 2,503,300 | 880,400 | 1,817,200 | 1,724,000 | 1,096,000 |
| Net Cash Flow | $1,622,900 | $-936,800 | $93,200 | $628,000 | $846,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,238,700 | 5,640,100 | 6,079,000 | 1,445,700 | 4,606,100 |
| Capital Expenditure | -375,200 | -253,500 | -349,900 | -331,400 | -454,900 |
| Free Cash Flow | 6,863,500 | 5,386,600 | 5,729,100 | 1,114,300 | 4,151,200 |